O. Bouchaud, N. Muehlberger, P. Parola, G. Calleri, A. Matteelli et al., Therapy of uncomplicated falciparum malaria in Europe: MALTHER ??? a prospective observational multicentre study, Malaria Journal, vol.11, issue.1, p.212, 2012.
DOI : 10.1016/0035-9203(95)90500-6

. Société-de-pathologie-infectieuse-de-langue-française, Management and prevention of imported Plasmodium falciparum malaria (Revision, of the 1999 Consensus Conference), pp.68-117, 2007.

A. Hudson, Lapinone, menoctone, hydroxynaphtoquinones and similar structures In Handbook of experimental pharmacology, antimalarial drugs, pp.343-361

A. Hudson, A. Randall, M. Fry, C. Ginger, B. Hill et al., Novel anti-malarial hydroxynaphthoquinones with potent broad spectrum anti-protozoal activity, Parasitology, vol.79, issue.01, pp.45-55, 1985.
DOI : 10.1016/0003-2697(73)90097-3

W. Gutteridge and . Chemotherapy, In Modern parasitology, pp.218-239, 1993.

P. Chiodini, C. Conlon, D. Hutchinson, J. Farquhar, A. Hall et al., malaria, Journal of Antimicrobial Chemotherapy, vol.36, issue.6, pp.1073-1078, 1995.
DOI : 10.1093/jac/36.6.1073

D. Bustos, C. Canfield, E. Canete-miguel, and D. Hutchinson, Malaria in the Philippines, The Journal of Infectious Diseases, vol.179, issue.6, pp.1587-1590, 1999.
DOI : 10.1086/314770

F. De-alencar, C. Cerutti, R. Durlacher, M. Boulos, F. Alves et al., Atovaquone and Proguanil for the Treatment of Malaria in Brazil, The Journal of Infectious Diseases, vol.175, issue.6, pp.1544-1547, 1997.
DOI : 10.1086/516497

S. Looareesuwan, P. Wilairatana, K. Chalermarut, Y. Rattanapong, C. Canfield et al., Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand, Am J Trop Med Hyg, vol.60, pp.526-532, 1999.

M. Mulenga, T. Sukwa, C. Canfield, and D. Hutchinson, Atovaquone and proguanil versus pyrimethamine/sulfadoxine for the treatment of acute falciparum malaria in zambia, Clinical Therapeutics, vol.21, issue.5, pp.841-852, 1999.
DOI : 10.1016/S0149-2918(99)80006-X

P. Radloff, J. Philipps, M. Nkeyi, D. Hutchinson, and P. Kremsner, Atovaquone and proguanil for Plasmodium falciparum malaria, The Lancet, vol.347, issue.9014, pp.1511-1514, 1996.
DOI : 10.1016/S0140-6736(96)90671-6

O. Bouchaud, E. Monlun, K. Muanza, A. Fontanet, T. Scott et al., Atovaquone plus proguanil versus halofantrine for the treatment of imported acute uncomplicated Plasmodium falciparum malaria in non-immune adults: a randomized comparative trial, Am J Trop Med Hyg, vol.63, pp.274-279, 2000.

A. Hitani, T. Nakamura, H. Ohtomo, Y. Nawa, and M. Kimura, Efficacy and safety of atovaquone-proguanil compared with mefloquine in the treatment of nonimmune patients with uncomplicated P. falciparum malaria in Japan, Journal of Infection and Chemotherapy, vol.12, issue.5, pp.277-282, 2006.
DOI : 10.1007/s10156-006-0465-8

M. Van-agtmael, O. Bouchaud, D. Malvy, J. Delmont, M. Danis et al., The comparative efficacy and tolerability of CGP 56697 (artemether+lumefantrine) versus halofantrine in the treatment of uncomplicated falciparum malaria in travellers returning from the Tropics to The Netherlands and France, International Journal of Antimicrobial Agents, vol.12, issue.2, pp.159-169, 1999.
DOI : 10.1016/S0924-8579(99)00070-9

D. Malvy, F. Djossou, R. Vatan, T. Pistone, G. Etienne et al., Experience with the combination atovaquone-proguanil in the treatment of uncomplicated Plasmodium falciparum malaria?report of 112 cases] (in French) Med Trop (Mars), pp.229-231, 2002.

S. Thybo, I. Gjorup, A. Ronn, D. Meyrowitsch, and I. Bygberg, Atovaquone-Proguanil (Malarone): an Effective Treatment for Uncomplicated Plasmodium falciparum Malaria in Travelers from Denmark, Journal of Travel Medicine, vol.11, issue.4, pp.220-223, 2004.
DOI : 10.2310/7060.2004.19005

R. Vatan, T. Pistone, P. Millet, G. Etienne, P. Mercié et al., Analyse r??trospective de 107 cas de paludisme d???importation chez l???adulte, La Presse M??dicale, vol.35, issue.4, pp.571-577, 2006.
DOI : 10.1016/S0755-4982(06)74642-5

E. Bottieau, J. Clerinx, R. Colebunders, E. Van-den-enden, R. Wouters et al., Selective ambulatory management of imported falciparum malaria: a 5-year prospective study, European Journal of Clinical Microbiology & Infectious Diseases, vol.353, issue.Suppl, pp.181-188, 2007.
DOI : 10.1007/s10096-007-0264-x

P. Parola, P. Minodier, G. Soula, Y. Jaffré, S. Badiaga et al., Le paludisme d'importation ????l'H??pital-Nord de??Marseille en??2001???2003??: ??tude prospective de??352??cas, M??decine et Maladies Infectieuses, vol.35, issue.10, pp.482-488, 2001.
DOI : 10.1016/j.medmal.2005.05.006

S. Ranque, B. Marchou, D. Malvy, E. Adehossi, R. Laganier et al., Treatment of imported malaria in adults: a multicentre study in France, QJM, vol.98, issue.10, pp.737-743, 2005.
DOI : 10.1093/qjmed/hci110

T. Pistone, A. Diallo, M. Receveur, R. Mansour, J. Roger-schmeltz et al., Imported malaria in University Hospital Center of Bordeaux, France, 2000???2007. A comparison study with the French national epidemiological data, Bulletin de la Soci??t?? de pathologie exotique, vol.35, issue.2, pp.104-110, 2000.
DOI : 10.1007/s13149-010-0045-4

T. Jelinek, C. Schulte, R. Behrens, M. Grobusch, J. Coulaud et al., Imported Falciparum Malaria in Europe: Sentinel Surveillance Data from the European Network on Surveillance of Imported Infectious Diseases, Clinical Infectious Diseases, vol.34, issue.5, pp.572-576, 2002.
DOI : 10.1086/338235

D. Acremont, V. Landry, P. Darioli, R. Stuerchler, D. Pécoud et al., Treatment of imported malaria in an ambulatory setting: prospective study * Commentary: Should patients with imported malaria routinely be admitted?, BMJ, vol.324, issue.7342, pp.875-877, 2002.
DOI : 10.1136/bmj.324.7342.875

Y. Kockaerts, S. Vanhees, D. Knockaert, J. Verhaegen, M. Lontie et al., Imported malaria in the 1990s: a review of 101 patients, European Journal of Emergency Medicine, vol.8, issue.4, pp.287-290, 2001.
DOI : 10.1097/00063110-200112000-00007

C. Hatz, J. Soto, H. Nothdurft, T. Zoller, T. Weitzel et al., Treatment of acute uncomplicated falciparum malaria with artemether-lumefantrine in nonimmune populations: a safety

A. Osei-akoto, L. Orton, and S. Owusu-ofori, Atovaquone-proguanil for treating uncomplicated malaria, Cochrane Database Syst Rev, vol.19, issue.4, p.4529, 2005.

P. Giao, D. Vries, P. Hung, L. Binh, T. Nam et al., CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone-proguanil against falciparum malaria in Vietnam, Tropical Medicine and International Health, vol.17, issue.2, pp.209-216, 2004.
DOI : 10.1098/rstb.1999.0426

M. Makanga and S. Krudsood, The clinical efficacy of artemether/lumefantrine (Coartem??), Malaria Journal, vol.8, issue.Suppl 1, p.5, 2009.
DOI : 10.1186/1475-2875-8-S1-S5

P. Parola, S. Ranque, S. Badiaga, M. Niang, O. Blin et al., Controlled Trial of 3-Day Quinine-Clindamycin Treatment versus 7-Day Quinine Treatment for Adult Travelers with Uncomplicated Falciparum Malaria Imported from the Tropics, Antimicrobial Agents and Chemotherapy, vol.45, issue.3, pp.932-935, 2001.
DOI : 10.1128/AAC.45.3.932-935.2001

R. Durand, V. Prendki, J. Cailhol, V. Hubert, P. Ralaimazava et al., Malaria and Atovaquone-Proguanil Treatment Failure, Emerging Infectious Diseases, vol.14, issue.2, pp.320-322, 2008.
DOI : 10.3201/eid1402.070945
URL : http://doi.org/10.3201/eid1402.070945

T. Miura, M. Kimura, T. Koibuchi, T. Endo, H. Nakamura et al., Clinical characteristics of imported malaria in Japan: analysis at a referral hospital, Am J Trop Med Hyg, vol.73, pp.599-603, 2005.

L. Hartjes, L. Baumann, and J. Henriques, Travel Health Risk Perceptions and Prevention Behaviors of US Study Abroad Students, Journal of Travel Medicine, vol.16, issue.5, pp.338-343, 2009.
DOI : 10.1111/j.1708-8305.2009.00322.x

E. Rutebemberwa, X. Nsabagasani, G. Pariyo, G. Tomson, S. Peterson et al., Use of drugs, perceived drug efficacy and preferred providers for febrile children: implications for home management of fever, Malaria Journal, vol.8, issue.1, p.131, 2009.
DOI : 10.1186/1475-2875-8-131

Z. Hussein, J. Eaves, D. Hutchinson, and C. Canfield, Population pharmacokinetics of atovaquone in patients with acute malaria caused by Plasmodium falciparum*, Clinical Pharmacology & Therapeutics, vol.42, issue.5, pp.518-530, 1997.
DOI : 10.1016/S0009-9236(97)90132-6

S. Looareesuwan, J. Chulay, C. Canfield, and D. Hutchinson, Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria: malarone clinical trials study group, Am J Trop Med Hyg, vol.60, pp.533-541, 1999.

K. Mckeage and L. Scott, Atovaquone/Proguanil, Drugs, vol.338, issue.9245, pp.597-623, 2003.
DOI : 10.2165/00003495-200363060-00006

A. Boggild, M. Parise, L. Lewis, and K. Kain, Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II)

C. Menendez, A. Fleming, and P. Alonso, Malaria-related Anaemia, Parasitology Today, vol.16, issue.11, pp.469-476, 2000.
DOI : 10.1016/S0169-4758(00)01774-9

R. Price, J. Simpson, F. Nosten, C. Luxemburger, L. Hkirjaroen et al., Factors contributing to anemia after uncomplicated falciparum malaria, Am J Trop Med Hyg, vol.65, pp.614-622, 2001.